Skip to main content
TipRanks
Go Ultimate75% OFF

GREGORY J. FLESHER Insider Profile

4 Followers

GREGORY J. FLESHER, President & CEO, Director at OnKure Therapeutics, holds 115.20K shares in OnKure Therapeutics (Ticker: OKUR), holds 156.92K shares in Eledon Pharmaceuticals (Ticker: ELDN).

GREGORY J. FLESHER's Trading History

OKUR
OnKure Therapeutics
Dec 14, 2021President & CEO, DirectorUninformative Buy―$316.80K
ELDN
Eledon Pharmaceuticals
May 22, 2019CEO, DirectorInformative Sell28.54K$309.13K

You May Also Like

GREGORY J. FLESHER insider profile FAQ

What is the percentage of profitable transactions made by GREGORY J. FLESHER?
The percentage of profitable transactions made by GREGORY J. FLESHER is 33%.
What is the average return per transaction made by GREGORY J. FLESHER?
The average return per transaction made by GREGORY J. FLESHER is -6.60%.
What stocks does GREGORY J. FLESHER hold?
GREGORY J. FLESHER holds: OKUR, ELDN stocks.
What was GREGORY J. FLESHER's most profitable transaction?
GREGORY J. FLESHER’s most profitable transaction was an Informative Sell of ELDN stock on May 22, 2019. The return on the trade was 46.80%.
What is GREGORY J. FLESHER's role in OnKure Therapeutics?
GREGORY J. FLESHER's role in OnKure Therapeutics is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.